Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Director | $21.4M | -$79.7M | -78.9% | Sep 10, 2024 |
ABUS | Arbutus Biopharma Corp | Director | $358K | -$32.6K | -8.35% | Aug 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|